Insider Trades151 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 8,734 | $143.52 | $17.2B | -5.68% | +39.91% | $1.3M | +0.00% | 10b5-1 | Sell Now |
| Jul 9, 2026 | Sell | NBIX | Darin Lippoldt | Chief Legal Officer | 20,000 | $130.55 | $17.2B | -5.68% | +39.91% | $2.6M | +0.00% | 10b5-1 | Sell Now |
| Jul 7, 2026 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 29,142 | $141.09 | $17.2B | -5.68% | +39.91% | $4.1M | +0.00% | 10b5-1 | Sell Now |
| Jun 26, 2026 | Sell | NBIX | Darin Lippoldt | Chief Legal Officer | 20,000 | $125.82 | $17.2B | -5.68% | +39.91% | $2.5M | +0.00% | 10b5-1 | Sell Now |
| Jun 5, 2026 | Sell | NBIX | Jude Onyia | Chief Scientific Officer | 2,441 | $163.88 | $17.2B | -5.68% | +39.91% | $400.0K | -9.44% | — | Sell Now |
| Jun 2, 2026 | Sell | NBIX | Sanjay Chandru Keswani | Chief Medical Officer | 1,733 | $154.84 | $17.2B | -5.68% | +39.91% | $268.3K | -13.49% | — | Sell Now |
| Jun 2, 2026 | Sell | NBIX | Julie Cooke | Chief Human Resources Officer | 61,902 | $126.08 | $17.2B | -5.68% | +39.91% | $7.8M | -4.99% | 10b5-1 | Sell Now |
| Jun 1, 2026 | Sell | NBIX | Jude Onyia | Chief Scientific Officer | 22,000 | $122.49 | $17.2B | -5.68% | +39.91% | $2.7M | +0.00% | 10b5-1 | Sell Now |
| May 29, 2026 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 4,522 | $117.87 | $17.2B | -5.68% | +39.91% | $533.0K | +0.00% | 10b5-1 | Sell Now |
| May 27, 2026 | Sell | NBIX | Jude Onyia | Chief Scientific Officer | 22,000 | $120.14 | $17.2B | -5.68% | +39.91% | $2.6M | +0.00% | 10b5-1 | Sell Now |
| May 26, 2026 | Sell | NBIX | David W. Boyer | Chief Corp. Affairs Officer | 3,888 | $156.64 | $17.2B | -5.68% | +39.91% | $609.0K | -33.27% | 10b5-1 | Sell Now |
| Mar 4, 2026 | Sell | NBIX | Matt Abernethy | Chief Financial Officer | 2,249 | $133.44 | $17.2B | -5.68% | +39.91% | $300.1K | -4.99% | — | Sell Now |
| Feb 20, 2026 | Sell | NBIX | Jude Onyia | Chief Scientific Officer | 3,110 | $128.63 | $17.2B | -5.68% | +39.91% | $400.0K | -10.81% | — | Sell Now |
| Feb 12, 2026 | Sell | NBIX | Julie Cooke | Chief Human Resources Officer | 7,698 | $124.02 | $17.2B | -5.68% | +39.91% | $954.7K | -4.56% | — | Sell Now |
| Feb 12, 2026 | Sell | NBIX | David W. Boyer | Chief Corp. Affairs Officer | 8,052 | $124.01 | $17.2B | -5.68% | +39.91% | $998.5K | -9.51% | — | Sell Now |
| Feb 12, 2026 | Sell | NBIX | Darin Lippoldt | Chief Legal Officer | 8,923 | $118.93 | $17.2B | -5.68% | +39.91% | $1.1M | -2.79% | — | Sell Now |
| Feb 12, 2026 | Sell | NBIX | Matt Abernethy | Chief Financial Officer | 9,124 | $123.99 | $17.2B | -5.68% | +39.91% | $1.1M | -3.85% | — | Sell Now |
| Feb 12, 2026 | Sell | NBIX | Kyle Gano | Chief Executive Officer | 10,621 | $123.87 | $17.2B | -5.68% | +39.91% | $1.3M | -1.41% | — | Sell Now |
| Feb 12, 2026 | Sell | NBIX | Eric Benevich | Chief Commercial Officer | 12,227 | $124.03 | $17.2B | -5.68% | +39.91% | $1.5M | -4.16% | — | Sell Now |
| Feb 12, 2026 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 13,126 | $124.05 | $17.2B | -5.68% | +39.91% | $1.6M | -13.92% | — | Sell Now |
| Feb 12, 2026 | Sell | NBIX | Jude Onyia | Chief Scientific Officer | 15,099 | $124.02 | $17.2B | -5.68% | +39.91% | $1.9M | -8.41% | — | Sell Now |
| Jan 31, 2026 | Sell | NBIX | Jude Onyia | Chief Scientific Officer | 142 | $136.06 | $17.2B | -5.68% | +39.91% | $19.3K | -0.88% | — | Sell Now |
| Jan 31, 2026 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 475 | $136.06 | $17.2B | -5.68% | +39.91% | $64.6K | -8.59% | — | Sell Now |
| Jan 31, 2026 | Sell | NBIX | Julie Cooke | Chief Human Resources Officer | 997 | $136.06 | $17.2B | -5.68% | +39.91% | $135.7K | -3.49% | — | Sell Now |
| Jan 31, 2026 | Sell | NBIX | David W. Boyer | Chief Corp. Affairs Officer | 1,189 | $136.06 | $17.2B | -5.68% | +39.91% | $161.8K | -20.15% | — | Sell Now |
| Jan 31, 2026 | Sell | NBIX | Eric Benevich | Chief Commercial Officer | 1,292 | $136.06 | $17.2B | -5.68% | +39.91% | $175.8K | -2.39% | — | Sell Now |
| Jan 31, 2026 | Sell | NBIX | Darin Lippoldt | Chief Legal Officer | 1,335 | $136.06 | $17.2B | -5.68% | +39.91% | $181.6K | -2.72% | — | Sell Now |
| Jan 31, 2026 | Sell | NBIX | Matt Abernethy | Chief Financial Officer | 1,368 | $136.06 | $17.2B | -5.68% | +39.91% | $186.1K | -3.56% | — | Sell Now |
| Jan 31, 2026 | Sell | NBIX | Kyle Gano | Chief Executive Officer | 1,580 | $136.06 | $17.2B | -5.68% | +39.91% | $215.0K | -1.10% | — | Sell Now |
| Jan 16, 2026 | Sell | NBIX | Kyle Gano | Chief Executive Officer | 72,800 | $84.35 | $17.2B | -5.68% | +39.91% | $6.1M | +0.00% | 10b5-1 | Sell Now |
| Jan 8, 2026 | Buy | NBIX | Darin Lippoldt | Chief Legal Officer | 3,349 | $35.99 | $17.2B | -5.68% | +39.91% | $120.5K | +7.72% | — | Sell Now |
| Dec 8, 2025 | Sell | NBIX | Darin Lippoldt | Chief Legal Officer | 8,752 | $101.44 | $17.2B | -5.68% | +39.91% | $887.8K | +0.00% | 10b5-1 | Sell Now |
| Nov 29, 2025 | Sell | NBIX | Jude Onyia | Chief Scientific Officer | 2,248 | $152.16 | $17.2B | -5.68% | +39.91% | $342.1K | -12.40% | — | Sell Now |
| Nov 28, 2025 | Buy | NBIX | Eric Benevich | Chief Commercial Officer | 12,830 | $35.99 | $17.2B | -5.68% | +39.91% | $461.8K | +28.58% | — | Sell Now |
| Nov 28, 2025 | Sell | NBIX | Eric Benevich | Chief Commercial Officer | 11,940 | $93.86 | $17.2B | -5.68% | +39.91% | $1.1M | +0.00% | 10b5-1 | Sell Now |
| Nov 4, 2025 | Sell | NBIX | Kyle Gano | Chief Executive Officer | 300 | $141.97 | $17.2B | -5.68% | +39.91% | $42.6K | -0.21% | 10b5-1 | Sell Now |
| Sep 3, 2025 | Sell | NBIX | Jude Onyia | Chief Scientific Officer | 1,470 | $136.11 | $17.2B | -5.68% | +39.91% | $200.1K | -9.69% | — | Sell Now |
| Aug 5, 2025 | Sell | NBIX | Jude Onyia | Chief Scientific Officer | 3,116 | $128.39 | $17.2B | -5.68% | +39.91% | $400.1K | -17.04% | — | Sell Now |
| Jul 10, 2025 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 914 | $107.01 | $17.2B | -5.68% | +39.91% | $97.8K | +0.00% | 10b5-1 | Sell Now |
| Jul 9, 2025 | Sell | NBIX | Jude Onyia | Chief Scientific Officer | 119,638 | $107.60 | $17.2B | -5.68% | +39.91% | $12.9M | +0.00% | 10b5-1 | Sell Now |
| Jul 2, 2025 | Sell | NBIX | Jude Onyia | Chief Scientific Officer | 40,724 | $107.44 | $17.2B | -5.68% | +39.91% | $4.4M | +0.00% | 10b5-1 | Sell Now |
| May 16, 2025 | Buy | NBIX | Julie Cooke | Chief Human Resources Officer | 6,468 | $61.82 | $17.2B | -5.68% | +39.91% | $399.9K | +31.72% | — | Sell Now |
| Feb 13, 2025 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 1,471 | $116.71 | $17.2B | -5.68% | +39.91% | $171.7K | -2.55% | 10b5-1 | Sell Now |
| Feb 13, 2025 | Sell | NBIX | Julie Cooke | Chief Human Resources Officer | 1,551 | $116.78 | $17.2B | -5.68% | +39.91% | $181.1K | -1.85% | 10b5-1 | Sell Now |
| Feb 13, 2025 | Sell | NBIX | David W. Boyer | Chief Corp. Affairs Officer | 1,785 | $116.74 | $17.2B | -5.68% | +39.91% | $208.4K | -3.13% | 10b5-1 | Sell Now |
| Feb 13, 2025 | Sell | NBIX | Eric Benevich | Chief Commercial Officer | 2,154 | $116.73 | $17.2B | -5.68% | +39.91% | $251.4K | -1.42% | 10b5-1 | Sell Now |
| Feb 13, 2025 | Sell | NBIX | Eiry Roberts | Chief Medical Officer | 2,218 | $116.44 | $17.2B | -5.68% | +39.91% | $258.3K | -1.31% | 10b5-1 | Sell Now |
| Feb 13, 2025 | Sell | NBIX | Kyle Gano | Chief Executive Officer | 2,558 | $116.85 | $17.2B | -5.68% | +39.91% | $298.9K | -0.61% | 10b5-1 | Sell Now |
| Feb 13, 2025 | Sell | NBIX | Matt Abernethy | Chief Financial Officer | 2,558 | $116.86 | $17.2B | -5.68% | +39.91% | $298.9K | -1.84% | 10b5-1 | Sell Now |
| Feb 13, 2025 | Sell | NBIX | Jude Onyia | Chief Scientific Officer | 2,879 | $116.79 | $17.2B | -5.68% | +39.91% | $336.2K | -2.48% | 10b5-1 | Sell Now |
| Feb 12, 2025 | Sell | NBIX | Darin Lippoldt | Chief Legal Officer | 2,374 | $107.41 | $17.2B | -5.68% | +39.91% | $255.0K | -1.28% | 10b5-1 | Sell Now |
| Feb 10, 2025 | Sell | NBIX | Julie Cooke | Chief Human Resources Officer | 700 | $118.28 | $17.2B | -5.68% | +39.91% | $82.8K | -3.58% | 10b5-1 | Sell Now |
| Feb 10, 2025 | Sell | NBIX | David W. Boyer | Chief Corp. Affairs Officer | 700 | $118.31 | $17.2B | -5.68% | +39.91% | $82.8K | -25.95% | 10b5-1 | Sell Now |
| Feb 10, 2025 | Sell | NBIX | Darin Lippoldt | Chief Legal Officer | 911 | $118.25 | $17.2B | -5.68% | +39.91% | $107.7K | -2.14% | 10b5-1 | Sell Now |
| Feb 10, 2025 | Sell | NBIX | Eiry Roberts | Chief Medical Officer | 980 | $118.22 | $17.2B | -5.68% | +39.91% | $115.9K | -2.86% | 10b5-1 | Sell Now |
| Feb 10, 2025 | Sell | NBIX | Matt Abernethy | Chief Financial Officer | 980 | $118.27 | $17.2B | -5.68% | +39.91% | $115.9K | -2.84% | 10b5-1 | Sell Now |
| Feb 10, 2025 | Sell | NBIX | Eric Benevich | Chief Commercial Officer | 980 | $118.31 | $17.2B | -5.68% | +39.91% | $115.9K | -2.24% | 10b5-1 | Sell Now |
| Feb 10, 2025 | Sell | NBIX | Kyle Gano | Chief Executive Officer | 980 | $118.39 | $17.2B | -5.68% | +39.91% | $116.0K | -0.71% | 10b5-1 | Sell Now |
| Jan 31, 2025 | Sell | NBIX | Jude Onyia | Chief Scientific Officer | 126 | $152.97 | $17.2B | -5.68% | +39.91% | $19.3K | -0.79% | 10b5-1 | Sell Now |
| Jan 31, 2025 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 1,045 | $150.81 | $17.2B | -5.68% | +39.91% | $157.6K | -12.78% | 10b5-1 | Sell Now |
| Jan 31, 2025 | Sell | NBIX | David W. Boyer | Chief Corp. Affairs Officer | 1,104 | $152.94 | $17.2B | -5.68% | +39.91% | $168.8K | -24.16% | 10b5-1 | Sell Now |
| Jan 31, 2025 | Sell | NBIX | Eric Benevich | Chief Commercial Officer | 1,207 | $152.94 | $17.2B | -5.68% | +39.91% | $184.6K | -2.66% | 10b5-1 | Sell Now |
| Jan 31, 2025 | Sell | NBIX | Darin Lippoldt | Chief Legal Officer | 1,250 | $152.91 | $17.2B | -5.68% | +39.91% | $191.1K | -2.81% | 10b5-1 | Sell Now |
| Jan 31, 2025 | Sell | NBIX | Matt Abernethy | Chief Financial Officer | 1,283 | $152.87 | $17.2B | -5.68% | +39.91% | $196.1K | -3.52% | 10b5-1 | Sell Now |
| Jan 31, 2025 | Sell | NBIX | Eiry Roberts | Chief Medical Officer | 1,457 | $152.80 | $17.2B | -5.68% | +39.91% | $222.6K | -3.98% | 10b5-1 | Sell Now |
| Jan 31, 2025 | Sell | NBIX | Kyle Gano | Chief Executive Officer | 1,541 | $152.87 | $17.2B | -5.68% | +39.91% | $235.6K | -1.09% | 10b5-1 | Sell Now |
| Jan 31, 2025 | Sell | NBIX | Julie Cooke | Chief Human Resources Officer | 1,740 | $152.89 | $17.2B | -5.68% | +39.91% | $266.0K | -4.27% | 10b5-1 | Sell Now |
| Jan 15, 2025 | Sell | NBIX | Kyle Gano | Chief Executive Officer | 130,000 | $87.25 | $17.2B | -5.68% | +39.91% | $11.3M | +0.00% | 10b5-1 | Sell Now |
| Dec 31, 2024 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 544 | $108.56 | $17.2B | -5.68% | +39.91% | $59.1K | +0.00% | 10b5-1 | Sell Now |
| Dec 17, 2024 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 2,182 | $107.01 | $17.2B | -5.68% | +39.91% | $233.5K | +0.00% | 10b5-1 | Sell Now |
| Nov 29, 2024 | Sell | NBIX | Jude Onyia | Chief Scientific Officer | 2,331 | $126.29 | $17.2B | -5.68% | +39.91% | $294.4K | -10.50% | 10b5-1 | Sell Now |
| Nov 8, 2024 | Buy | NBIX | Eiry Roberts | Chief Medical Officer | 7,345 | $81.67 | $17.2B | -5.68% | +39.91% | $599.9K | +6.39% | — | Sell Now |
| Oct 3, 2024 | Sell | NBIX | David W. Boyer | Chief Corp. Affairs Officer | 1,295 | $113.66 | $17.2B | -5.68% | +39.91% | $147.2K | -77.45% | 10b5-1 | Sell Now |
| Sep 13, 2024 | Sell | NBIX | David W. Boyer | Chief Corp. Affairs Officer | 3,461 | $121.88 | $17.2B | -5.68% | +39.91% | $421.8K | -67.43% | 10b5-1 | Sell Now |
| Aug 13, 2024 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 10,186 | $136.19 | $17.2B | -5.68% | +39.91% | $1.4M | -9.13% | 10b5-1 | Sell Now |
| Aug 13, 2024 | Sell | NBIX | Matt Abernethy | Chief Financial Officer | 28,200 | $111.99 | $17.2B | -5.68% | +39.91% | $3.2M | +0.00% | 10b5-1 | Sell Now |
| Aug 6, 2024 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 546 | $113.36 | $17.2B | -5.68% | +39.91% | $61.9K | +0.00% | 10b5-1 | Sell Now |
| Aug 1, 2024 | Sell | NBIX | Darin Lippoldt | Chief Legal Officer | 5,992 | $116.52 | $17.2B | -5.68% | +39.91% | $698.2K | +0.00% | 10b5-1 | Sell Now |
| Aug 1, 2024 | Sell | NBIX | Julie Cooke | Chief Human Resources Officer | 25,264 | $107.54 | $17.2B | -5.68% | +39.91% | $2.7M | +0.00% | 10b5-1 | Sell Now |
| Jul 16, 2024 | Sell | NBIX | Julie Cooke | Chief Human Resources Officer | 1,800 | $105.93 | $17.2B | -5.68% | +39.91% | $190.7K | +0.00% | 10b5-1 | Sell Now |
| Jul 16, 2024 | Sell | NBIX | Matt Abernethy | Chief Financial Officer | 1,800 | $111.82 | $17.2B | -5.68% | +39.91% | $201.3K | +0.00% | 10b5-1 | Sell Now |
| Jul 16, 2024 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 4,814 | $131.12 | $17.2B | -5.68% | +39.91% | $631.2K | -0.99% | 10b5-1 | Sell Now |
| Jul 16, 2024 | Sell | NBIX | Darin Lippoldt | Chief Legal Officer | 14,008 | $114.51 | $17.2B | -5.68% | +39.91% | $1.6M | +0.00% | 10b5-1 | Sell Now |
| Jul 1, 2024 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 544 | $108.56 | $17.2B | -5.68% | +39.91% | $59.1K | +0.00% | 10b5-1 | Sell Now |
| Jul 1, 2024 | Sell | NBIX | Julie Cooke | Chief Human Resources Officer | 20,000 | $101.00 | $17.2B | -5.68% | +39.91% | $2.0M | +0.00% | 10b5-1 | Sell Now |
| May 31, 2024 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 546 | $107.78 | $17.2B | -5.68% | +39.91% | $58.9K | +0.00% | 10b5-1 | Sell Now |
| May 14, 2024 | Sell | NBIX | Matt Abernethy | Chief Financial Officer | 60,000 | $105.77 | $17.2B | -5.68% | +39.91% | $6.3M | +0.00% | 10b5-1 | Sell Now |
| May 6, 2024 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 546 | $109.78 | $17.2B | -5.68% | +39.91% | $59.9K | +0.00% | 10b5-1 | Sell Now |
| Apr 15, 2024 | Sell | NBIX | Eric Benevich | Chief Commercial Officer | 39,636 | $107.29 | $17.2B | -5.68% | +39.91% | $4.3M | +0.00% | 10b5-1 | Sell Now |
| Apr 1, 2024 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 544 | $108.16 | $17.2B | -5.68% | +39.91% | $58.8K | +0.00% | 10b5-1 | Sell Now |
| Mar 21, 2024 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 10,000 | $124.29 | $17.2B | -5.68% | +39.91% | $1.2M | +0.00% | 10b5-1 | Sell Now |
| Mar 14, 2024 | Sell | NBIX | Eric Benevich | Chief Commercial Officer | 150,000 | $110.14 | $17.2B | -5.68% | +39.91% | $16.5M | +0.00% | 10b5-1 | Sell Now |
| Mar 13, 2024 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 6,000 | $123.08 | $17.2B | -5.68% | +39.91% | $738.5K | +0.00% | 10b5-1 | Sell Now |
| Mar 8, 2024 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 4,000 | $123.02 | $17.2B | -5.68% | +39.91% | $492.1K | +0.00% | 10b5-1 | Sell Now |
| Feb 28, 2024 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 13,634 | $107.18 | $17.2B | -5.68% | +39.91% | $1.5M | +0.00% | 10b5-1 | Sell Now |
| Feb 28, 2024 | Sell | NBIX | Eric Benevich | Chief Commercial Officer | 150,000 | $94.18 | $17.2B | -5.68% | +39.91% | $14.1M | +0.00% | 10b5-1 | Sell Now |
| Feb 13, 2024 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 716 | $133.03 | $17.2B | -5.68% | +39.91% | $95.3K | -1.71% | 10b5-1 | Sell Now |
| Feb 13, 2024 | Sell | NBIX | Julie Cooke | Chief Human Resources Officer | 796 | $133.04 | $17.2B | -5.68% | +39.91% | $105.9K | -1.52% | 10b5-1 | Sell Now |
| Feb 13, 2024 | Sell | NBIX | Darin Lippoldt | Chief Legal Officer | 1,098 | $132.99 | $17.2B | -5.68% | +39.91% | $146.0K | -1.23% | 10b5-1 | Sell Now |
| Feb 13, 2024 | Sell | NBIX | Eric Benevich | Chief Commercial Officer | 1,098 | $133.01 | $17.2B | -5.68% | +39.91% | $146.1K | -1.23% | 10b5-1 | Sell Now |
| Feb 13, 2024 | Sell | NBIX | Eiry Roberts | Chief Medical Officer | 1,114 | $132.96 | $17.2B | -5.68% | +39.91% | $148.1K | -2.15% | 10b5-1 | Sell Now |
| Feb 13, 2024 | Sell | NBIX | Matt Abernethy | Chief Financial Officer | 1,352 | $132.85 | $17.2B | -5.68% | +39.91% | $179.6K | -1.56% | 10b5-1 | Sell Now |
| Feb 13, 2024 | Sell | NBIX | Kyle Gano | Chief Business Development Off | 1,352 | $132.89 | $17.2B | -5.68% | +39.91% | $179.7K | -0.71% | 10b5-1 | Sell Now |
| Feb 13, 2024 | Sell | NBIX | Jude Onyia | Chief Scientific Officer | 1,432 | $132.94 | $17.2B | -5.68% | +39.91% | $190.4K | -1.80% | 10b5-1 | Sell Now |
| Feb 13, 2024 | Buy | NBIX | Kevin Charles Gorman | Chief Executive Officer | 5,090 | $39.28 | $17.2B | -5.68% | +39.91% | $200.0K | +0.50% | — | Sell Now |
| Feb 13, 2024 | Sell | NBIX | David W. Boyer | Chief Corp. Affairs Officer | 1,811 | $133.07 | $17.2B | -5.68% | +39.91% | $241.0K | -3.65% | 10b5-1 | Sell Now |
| Feb 13, 2024 | Sell | NBIX | Kevin Charles Gorman | Chief Executive Officer | 2,832 | $133.02 | $17.2B | -5.68% | +39.91% | $376.7K | -0.43% | 10b5-1 | Sell Now |
| Feb 6, 2024 | Sell | NBIX | David W. Boyer | Chief Corp. Affairs Officer | 1,784 | $137.09 | $17.2B | -5.68% | +39.91% | $244.6K | -8.03% | 10b5-1 | Sell Now |
| Feb 6, 2024 | Sell | NBIX | Darin Lippoldt | Chief Legal Officer | 1,952 | $138.47 | $17.2B | -5.68% | +39.91% | $270.3K | -2.48% | 10b5-1 | Sell Now |
| Feb 6, 2024 | Sell | NBIX | Eiry Roberts | Chief Medical Officer | 2,101 | $138.49 | $17.2B | -5.68% | +39.91% | $291.0K | -4.50% | 10b5-1 | Sell Now |
| Feb 6, 2024 | Sell | NBIX | Eric Benevich | Chief Commercial Officer | 2,260 | $138.68 | $17.2B | -5.68% | +39.91% | $313.4K | -2.80% | 10b5-1 | Sell Now |
| Feb 6, 2024 | Sell | NBIX | Matt Abernethy | Chief Financial Officer | 2,260 | $138.73 | $17.2B | -5.68% | +39.91% | $313.5K | -3.64% | 10b5-1 | Sell Now |
| Feb 6, 2024 | Sell | NBIX | Julie Cooke | Chief Human Resources Officer | 2,544 | $138.61 | $17.2B | -5.68% | +39.91% | $352.6K | -3.49% | 10b5-1 | Sell Now |
| Feb 6, 2024 | Sell | NBIX | Kyle Gano | Chief Business Development Off | 2,580 | $139.16 | $17.2B | -5.68% | +39.91% | $359.0K | -0.96% | 10b5-1 | Sell Now |
| Feb 6, 2024 | Sell | NBIX | Kevin Charles Gorman | Chief Executive Officer | 5,314 | $138.74 | $17.2B | -5.68% | +39.91% | $737.3K | -0.52% | 10b5-1 | Sell Now |
| Jan 31, 2024 | Sell | NBIX | Jude Onyia | Chief Scientific Officer | 126 | $141.94 | $17.2B | -5.68% | +39.91% | $17.9K | -1.05% | 10b5-1 | Sell Now |
| Jan 31, 2024 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 1,045 | $140.65 | $17.2B | -5.68% | +39.91% | $147.0K | -7.35% | 10b5-1 | Sell Now |
| Jan 31, 2024 | Sell | NBIX | Eric Benevich | Chief Commercial Officer | 1,207 | $140.78 | $17.2B | -5.68% | +39.91% | $169.9K | -3.11% | 10b5-1 | Sell Now |
| Jan 31, 2024 | Sell | NBIX | Darin Lippoldt | Chief Legal Officer | 1,250 | $140.65 | $17.2B | -5.68% | +39.91% | $175.8K | -3.27% | 10b5-1 | Sell Now |
| Jan 31, 2024 | Sell | NBIX | Matt Abernethy | Chief Financial Officer | 1,283 | $140.72 | $17.2B | -5.68% | +39.91% | $180.5K | -4.34% | 10b5-1 | Sell Now |
| Jan 31, 2024 | Sell | NBIX | Eiry Roberts | Chief Medical Officer | 1,457 | $140.79 | $17.2B | -5.68% | +39.91% | $205.1K | -6.54% | 10b5-1 | Sell Now |
| Jan 31, 2024 | Sell | NBIX | Kyle Gano | Chief Business Development Off | 1,541 | $140.70 | $17.2B | -5.68% | +39.91% | $216.8K | -1.16% | 10b5-1 | Sell Now |
| Jan 31, 2024 | Sell | NBIX | Julie Cooke | Chief Human Resources Officer | 1,740 | $141.29 | $17.2B | -5.68% | +39.91% | $245.8K | -4.69% | 10b5-1 | Sell Now |
| Jan 31, 2024 | Sell | NBIX | David W. Boyer | Chief Corp. Affairs Officer | 2,096 | $140.80 | $17.2B | -5.68% | +39.91% | $295.1K | -16.28% | 10b5-1 | Sell Now |
| Jan 31, 2024 | Sell | NBIX | Kevin Charles Gorman | Chief Executive Officer | 2,707 | $140.69 | $17.2B | -5.68% | +39.91% | $380.8K | -0.54% | 10b5-1 | Sell Now |
| Jan 22, 2024 | Sell | NBIX | Darin Lippoldt | Chief Legal Officer | 20,000 | $109.44 | $17.2B | -5.68% | +39.91% | $2.2M | +0.00% | 10b5-1 | Sell Now |
| Jan 8, 2024 | Sell | NBIX | Kevin Charles Gorman | Chief Executive Officer | 335,716 | $76.30 | $17.2B | -5.68% | +39.91% | $25.6M | +0.00% | 10b5-1 | Sell Now |
| Jan 2, 2024 | Sell | NBIX | Kyle Gano | Chief Business Development Off | 150,000 | $75.53 | $17.2B | -5.68% | +39.91% | $11.3M | +0.00% | 10b5-1 | Sell Now |
| Dec 22, 2023 | Sell | NBIX | Eiry Roberts | Chief Medical Officer | 10,000 | $126.74 | $17.2B | -5.68% | +39.91% | $1.3M | -33.87% | 10b5-1 | Sell Now |
| Dec 22, 2023 | Sell | NBIX | Julie Cooke | Chief Human Resources Officer | 48,000 | $100.85 | $17.2B | -5.68% | +39.91% | $4.8M | +0.00% | 10b5-1 | Sell Now |
| Dec 12, 2023 | Sell | NBIX | Eiry Roberts | Chief Medical Officer | 27,850 | $100.68 | $17.2B | -5.68% | +39.91% | $2.8M | +0.00% | 10b5-1 | Sell Now |
| Dec 7, 2023 | Sell | NBIX | Eiry Roberts | Chief Medical Officer | 155,358 | $99.45 | $17.2B | -5.68% | +39.91% | $15.5M | +0.00% | 10b5-1 | Sell Now |
| Dec 6, 2023 | Sell | NBIX | Eiry Roberts | Chief Medical Officer | 16,792 | $98.92 | $17.2B | -5.68% | +39.91% | $1.7M | +0.00% | 10b5-1 | Sell Now |
| Dec 6, 2023 | Sell | NBIX | Darin Lippoldt | Chief Legal Officer | 41,660 | $81.55 | $17.2B | -5.68% | +39.91% | $3.4M | +0.00% | 10b5-1 | Sell Now |
| Nov 29, 2023 | Sell | NBIX | Jude Onyia | Chief Scientific Officer | 2,331 | $113.57 | $17.2B | -5.68% | +39.91% | $264.7K | -16.58% | 10b5-1 | Sell Now |
| Nov 27, 2023 | Sell | NBIX | Darin Lippoldt | Chief Legal Officer | 10,919 | $112.27 | $17.2B | -5.68% | +39.91% | $1.2M | -23.33% | 10b5-1 | Sell Now |
| Oct 2, 2023 | Sell | NBIX | David W. Boyer | Chief Corp. Affairs Officer | 1,437 | $112.68 | $17.2B | -5.68% | +39.91% | $161.9K | -22.70% | 10b5-1 | Sell Now |
| Sep 1, 2023 | Sell | NBIX | Julie Cooke | Chief Human Resources Officer | 824 | $110.93 | $17.2B | -5.68% | +39.91% | $91.4K | -4.56% | 10b5-1 | Sell Now |
| Aug 30, 2023 | Sell | NBIX | Darin Lippoldt | Chief Legal Officer | 190 | $108.39 | $17.2B | -5.68% | +39.91% | $20.6K | -0.40% | — | Sell Now |
| Aug 30, 2023 | Sell | NBIX | David W. Boyer | Chief Corp. Affairs Officer | 2,733 | $107.60 | $17.2B | -5.68% | +39.91% | $294.1K | -24.64% | 10b5-1 | Sell Now |
| Aug 28, 2023 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 1,431 | $107.52 | $17.2B | -5.68% | +39.91% | $153.9K | -19.44% | 10b5-1 | Sell Now |
| Aug 21, 2023 | Sell | NBIX | Ingrid Delaet | Chief Regulatory Officer | 1,404 | $107.42 | $17.2B | -5.68% | +39.91% | $150.8K | -23.21% | 10b5-1 | Sell Now |
| Aug 21, 2023 | Sell | NBIX | Eric Benevich | Chief Commercial Officer | 1,600 | $107.40 | $17.2B | -5.68% | +39.91% | $171.8K | -4.21% | 10b5-1 | Sell Now |
| Aug 21, 2023 | Sell | NBIX | David W. Boyer | Chief Corp. Affairs Officer | 1,600 | $107.41 | $17.2B | -5.68% | +39.91% | $171.9K | -20.53% | 10b5-1 | Sell Now |
| Aug 21, 2023 | Sell | NBIX | Darin Lippoldt | Chief Legal Officer | 2,132 | $107.39 | $17.2B | -5.68% | +39.91% | $229.0K | -4.34% | 10b5-1 | Sell Now |
| Aug 21, 2023 | Sell | NBIX | Matt Abernethy | Chief Financial Officer | 2,132 | $107.39 | $17.2B | -5.68% | +39.91% | $229.0K | -7.29% | 10b5-1 | Sell Now |
| Aug 21, 2023 | Sell | NBIX | Julie Cooke | Chief Human Resources Officer | 2,132 | $107.41 | $17.2B | -5.68% | +39.91% | $229.0K | -10.54% | 10b5-1 | Sell Now |
| Aug 21, 2023 | Sell | NBIX | Kyle Gano | Chief Business Development Off | 2,132 | $107.41 | $17.2B | -5.68% | +39.91% | $229.0K | -1.61% | 10b5-1 | Sell Now |
| Aug 21, 2023 | Sell | NBIX | Jude Onyia | Chief Scientific Officer | 3,198 | $107.37 | $17.2B | -5.68% | +39.91% | $343.4K | -24.91% | 10b5-1 | Sell Now |
| Aug 21, 2023 | Sell | NBIX | Eiry Roberts | Chief Medical Officer | 3,198 | $107.38 | $17.2B | -5.68% | +39.91% | $343.4K | -9.77% | 10b5-1 | Sell Now |
| Aug 21, 2023 | Sell | NBIX | Kevin Charles Gorman | Chief Executive Officer | 9,328 | $107.40 | $17.2B | -5.68% | +39.91% | $1.0M | -1.83% | 10b5-1 | Sell Now |